ZMB Site - Medical Faculty / University Hospital Essen
ZMB Research
Sites
Medical Faculty / University Hospital Essen
Prof. Dr. Dr.Jürgen Becker
Group: Translational Skin Cancer Research
ZMB Research Program: Oncology
MoreProf. Dr.Jan Buer
Director of: Institute of Medical Microbiology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Elke Cario
Group: Experimental Gastroenterology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Ulf Dittmer
Director of: Institute of Virology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Nicole Dünker
Group: Neuroanatomy
ZMB Research Program: Molecular and Chemical Cell Biology
MoreProf. Dr.Joachim Fandrey
Director of: Institute of Physiology
ZMB Research Program: Molecular and Chemical Cell Biology
MoreJun.-Prof. Dr.Katja Ferenz
Group: Institute of Physiology
ZMB Research Program: Molecular and Chemical Cell Biology
MoreProf. Dr.Katharina Fleischhauer
Director of: Institute for Experimental Cellular Therapy
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Stefanie Flohé
Group: Immunology Sepsis/Trauma
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Dagmar Führer-Sakel
Director of: Clinic for Endocrinology, Diabetology and Metabolism
ZMB Research Program: Oncology
MoreProf. Dr.Bernd Giebel
Group: Giebel Lab
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Barbara Grünwald
Group: Tumor Heterogeneity and Translational Systems Biology
ZMB Research Program: Oncology
MoreProf. Dr.Erich Gulbins
Director of: Department of Molecular Biology
ZMB Research Program: Oncology
MoreProf. Dr.Matthias Gunzer
Director of: Institute of Experimental Immunology & Imaging
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Wiebke Hansen
Group: Molecular Infection Immunology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Ulrike Hendgen-Cotta
Manager of: Cardio Science Labs
ZMB Research Program: Molecular and Chemical Cell Biology
MoreProf. Dr.Dirk M. Hermann
Group: Vascular Neurology, Dementia and Age Research
ZMB Research Program: Molecular and Chemical Cell Biology
MoreProf. Dr.Heike Heuer
Group: Molecular Thyroidology
ZMB Research Program: Molecular and Chemical Cell Biology
MorePD Dr.Josephine Herz
Group: Experimental Perinatal Neuroscience
ZMB Research Program: Molecular and Chemical Cell Biology
MoreProf. Dr.Anke Hinney
Group: LVR Clinic for Psychiatry Essen
ZMB Research Program: Molecular and Chemical Cell Biology
MoreProf. Dr.Peter Horn
Director of: Institute for Transfusion Medicine
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Carsten Kirschning
Group: Regulation of Pathogen-specific Immunity
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Diana Klein
Group: Vascular Remodeling & Normal Tissue Protection
ZMB Research Program: Oncology
MoreProf. Dr.Christoph Kleinschnitz
Director of: Clinic for Neurology
ZMB Research Program: Molecular and Chemical Cell Biology
MorePD Dr.Adalbert Krawczyk
Group: Clinic for Infectious Diseases
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Ralf Küppers
Director of: Institute of Cell Biology (Tumor Research)
ZMB Research Program: Oncology
MoreProf. Dr.Karl Sebastian Lang
Director of: Institute of Immunology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreJun.-Prof. Dr.Elisabeth Littwitz-Salomon
Group: Immune Metabolism in Infection and Cancer
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Dietmar Lohmann
Group: Ophthalmic Oncology and Genetics
ZMB Research Program: Molecular and Chemical Cell Biology
MoreProf. Dr.Katharina Lückerath
Group: Preclinical Theranostics in Nuclear Medicine
ZMB Research Program: Oncology
MoreDr.Samuel Peña-Llopis
Junior Group: Translational Genomics in Solid Tumors
ZMB Research Program: Oncology
MoreProf. Dr.Tienush Rassaf
Director of: Clinic for Cardiology and Vascular Medicine
ZMB Research Program: Oncology
MoreProf. Dr.Christian Reinhardt
Director of: Clinic for Hematology and Stem Cell Transplantation
ZMB Research Program: Oncology
MoreProf. Dr.Alexander Roesch
Group: Tumor Heterogeneity & Plasticity
ZMB Research Program: Oncology
MoreProf. Dr.Martin Schuler
Director of: Department of Medical Oncology
ZMB Research Program: Oncology
MoreProf. Dr.Winfried Siffert
Director of: Institute of Pharmacogenetics
ZMB Research Program: Molecular and Chemical Cell Biology
MoreProf. Dr. Dr.Jens Siveke
Group: Bridge Institute for Experimental Tumor Therapy
ZMB Research Program: Oncology
MorePD Dr.Kathrin Sutter
TRR60 Junior Research Group: Interferone-alpha Subtypes
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreProf. Dr.Kathrin Thedieck
Group: Metabolism, Senescence and Autophagy
ZMB Research Program: Molecular and Chemical Cell Biology
MoreDr.Silvia Vega-Rubín-de-Celis
Junior Research Group: Autophagy in Cancer
ZMB Research Program: Oncology
MoreProf. Dr.Gunther Wennemuth
Director of: Institute of Anatomy
ZMB Research Program: Molecular and Chemical Cell Biology
MoreProf. Dr.Astrid Westendorf
Group: Infection Immunology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
MoreSelected Publications
-
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors : A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 StudiesIn: Clinical Cancer Research Vol. 30 (2024) Nr. 4, pp. 719 - 728Online Full Text: dx.doi.org/
-
Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDSIn: Blood Vol. 144 (2024) Nr. 16, pp. 1747 - 1751Online Full Text: dx.doi.org/
-
Cranioencephalic functional lymphoid units in glioblastomaIn: Nature Medicine (2024) in pressOnline Full Text: dx.doi.org/ (Open Access)
-
Epigenetic alterations in patients with anorexia nervosa : A systematic reviewIn: Molecular Psychiatry (2024) in pressOnline Full Text: dx.doi.org/ (Open Access)
-
A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanomaIn: Cell Vol. 187 (2024) Nr. 1, pp. 166 - 183.e25Online Full Text: dx.doi.org/ (Open Access)
-
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III MelanomaIn: The New England Journal of Medicine (2024) in pressOnline Full Text: dx.doi.org/
-
Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophyIn: Acta Neuropathologica Vol. 147 (2024) Nr. 1, 53Online Full Text: dx.doi.org/ (Open Access)
-
Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRAIn: Nature Communications Vol. 15 (2024) Nr. 1, 63Online Full Text: dx.doi.org/ (Open Access)
-
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatmentIn: Nature Communications Vol. 15 (2024) Nr. 1, 4120Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNAIn: Blood Vol. 143 (2024) Nr. 6, pp. 522 - 534Online Full Text: dx.doi.org/
-
Retrotransposons are co-opted to activate hematopoietic stem cells and erythropoiesisIn: Science Vol. 386 (2024) Nr. 6722, pp. eado6836Online Full Text: dx.doi.org/
-
Structure-based discovery of first inhibitors targeting the helicase activity of human PIF1In: Nucleic Acids Research Vol. 52 (2024) Nr. 20, pp. 12616 - 12632Online Full Text: dx.doi.org/ (Open Access)
-
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replicationIn: Journal of Hepatology (2024) in pressOnline Full Text: dx.doi.org/ (Open Access)
-
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasisIn: Science Advances Vol. 10 (2024) Nr. 44, eadk8801Online Full Text: dx.doi.org/ (Open Access)
-
Genetic and functional analyses of CTBP2 in anorexia nervosa and body weight regulationIn: Molecular Psychiatry (2024)Online Full Text: dx.doi.org/ (Open Access)
-
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : Long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialIn: The Lancet Oncology Vol. 25 (2024) Nr. 9, pp. 1202 - 1212Online Full Text: dx.doi.org/
-
BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathwayIn: Science Advances Vol. 10 (2024) Nr. 36, eadn9361Online Full Text: dx.doi.org/ (Open Access)
-
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease : a secondary analysis from MARIPOSAIn: Annals of Oncology Vol. 35 (2024) Nr. 9, pp. 805 - 816Online Full Text: dx.doi.org/ (Open Access)
-
An atlas of cells in the human tonsilIn: Immunity Vol. 57 (2024) Nr. 2, pp. 379 - 399.e18Online Full Text: dx.doi.org/ (Open Access)
-
Cardiac wasting and cancerIn: European Heart Journal Vol. 45 (2024) Nr. 34, pp. 3135 - 3137Online Full Text: dx.doi.org/ (Open Access)
-
Evolutionary trajectories of small cell lung cancer under therapyIn: Nature Vol. 627 (2024) Nr. 8005, pp. 880 - 889Online Full Text: dx.doi.org/ (Open Access)
-
Correction to: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identificationIn: Nature Communications Vol. 15 (2024) Nr. 1, 2364Online Full Text: dx.doi.org/ (Open Access)
-
T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vesselsIn: Immunity (2024) in pressOnline Full Text: dx.doi.org/ (Open Access)
-
Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer : A multicentre retrospective studyIn: The Lancet Oncology Vol. 25 (2024) Nr. 9, pp. 1188 - 1201Online Full Text: dx.doi.org/ (Open Access)
-
Routine extracorporeal life support in infarct-related cardiogenic shock : 1-year results of the ECLS-SHOCK trialIn: European Heart Journal Vol. 45 (2024) Nr. 39, pp. 4200 - 4203Online Full Text: dx.doi.org/ (Open Access)
-
[¹⁷⁷Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2) : an open-label, randomised, phase 3 studyIn: Lancet Vol. 403 (2024) Nr. 10446, pp. 2807 - 2817Online Full Text: dx.doi.org/
-
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer : A randomized phase 2 trialIn: Nature Medicine Vol. 30 (2024) Nr. 6, pp. 1602 - 1611Online Full Text: dx.doi.org/ (Open Access)
-
Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation : Has Clinical Practice Outpaced the Evidence?In: Circulation Vol. 149 (2024) Nr. 13, pp. 1033 - 1052Online Full Text: dx.doi.org/
-
XPO1-Mediated mRNA Export of Genome Maintenance Regulators Drives Chemotherapy Resistance in Aggressive LymphomaIn: Cancer Research Vol. 84 (2024) Nr. 1, pp. 3 - 5Online Full Text: dx.doi.org/
-
Ripretinib versus sunitinib in gastrointestinal stromal tumor : ctDNA biomarker analysis of the phase 3 INTRIGUE trialIn: Nature Medicine Vol. 30 (2024) Nr. 2, pp. 498 - 506Online Full Text: dx.doi.org/ (Open Access)
-
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialIn: Lancet Vol. 403 (2024) Nr. 10445, pp. 2709 - 2719Online Full Text: dx.doi.org/
-
A second update on mapping the human genetic architecture of COVID-19In: Nature Vol. 621 (2023) pp. E7 - E26Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : Analyses of non-coding somatic drivers in 2,658 cancer whole genomesIn: Nature Vol. 614 (2023) pp. E40Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : The evolutionary history of 2,658 cancersIn: Nature Vol. 614 (2023) pp. E42Online Full Text: dx.doi.org/
-
Author Correction : Butler enables rapid cloud-based analysis of thousands of human genomesIn: Nature Biotechnology Vol. 41 (2023) Nr. 4, pp. 577Online Full Text: dx.doi.org/
-
Analyses of non-coding somatic drivers in 2,658 cancer whole genomesIn: Nature Vol. 578 (2023) Nr. 7793, pp. 102 - 111Online Full Text: dx.doi.org/
-
Author Correction : Patterns of somatic structural variation in human cancer genomesIn: Nature Vol. 614 (2023) Nr. 7948, pp. E38Online Full Text: dx.doi.org/ (Open Access)
-
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaIn: Clinical Cancer Research Vol. 29 (2023) Nr. 2, pp. 488 - 500Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : Genomic basis for RNA alterations in cancerIn: Nature Vol. 614 (2023) Nr. 7948, pp. E37Online Full Text: dx.doi.org/
-
Author Correction: : The repertoire of mutational signatures in human cancerIn: Nature Vol. 614 (2023) pp. E41Online Full Text: dx.doi.org/ (Open Access)
-
Comprehensive molecular characterization of mitochondrial genomes in human cancersIn: Nature Genetics Vol. 52 (2023) pp. 342 - 352Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancerIn: Nature Genetics Vol. 55 (2023) Nr. 6, pp. 1079Online Full Text: dx.doi.org/ (Open Access)
-
ComplexEye : a multi-lens array microscope for high-throughput embedded immune cell migration analysisIn: Nature Communications Vol. 14 (2023) Nr. 1, 8103Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancersIn: Nature Genetics Vol. 55 (2023) Nr. 6, pp. 1078Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotranspositionIn: Nature Genetics Vol. 55 (2023) Nr. 6, 1080Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction: The landscape of viral associations in human cancersIn: Nature Genetics Vol. 55 (2023) Nr. 6, pp. 1077Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencingIn: Nature Genetics Vol. 55 (2023) Nr. 6, 1076Online Full Text: dx.doi.org/ (Open Access)
-
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencingIn: Nature Genetics Vol. 52 (2023) pp. 331 - 341Online Full Text: dx.doi.org/ (Open Access)
-
Data-driven grading of acute graft-versus-host diseaseIn: Nature Communications Vol. 14 (2023) Nr. 1, 7799Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcriptionIn: Science Advances Vol. 9 (2023) Nr. 41, eadg5109Online Full Text: dx.doi.org/ (Open Access)
-
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 TrialIn: Clinical Cancer Research Vol. 29 (2023) Nr. 24, pp. 5057 - 5068Online Full Text: dx.doi.org/
-
Decrypting drug actions and protein modifications by dose- and time-resolved proteomicsIn: Science Vol. 380 (2023) Nr. 6640, pp. 93 - 101Online Full Text: dx.doi.org/
-
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytomaIn: Acta Neuropathologica Vol. 149 (2023) Nr. 4, pp. 551 - 564Online Full Text: dx.doi.org/ (Open Access)
-
Extracorporeal Life Support in Infarct-Related Cardiogenic ShockIn: The New England Journal of Medicine Vol. 389 (2023) Nr. 14, pp. 1286 - 1297Online Full Text: dx.doi.org/
-
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR) : An international, single-arm, phase 2 studyIn: The Lancet Oncology Vol. 24 (2023) Nr. 8, pp. 925 - 935Online Full Text: dx.doi.org/
-
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O) : disease-free survival results from a randomised, open-label, phase 2 trialIn: Lancet Vol. 402 (2023) Nr. 10404, pp. 798 - 808Online Full Text: dx.doi.org/
-
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapyIn: Blood Vol. 142 (2023) Nr. 25, pp. 2175 - 2191Online Full Text: dx.doi.org/ (Open Access)
-
The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latencyIn: Cell Reports Vol. 42 (2023) Nr. 11, 113285Online Full Text: dx.doi.org/ (Open Access)
-
Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and PentamerIn: Immunity Vol. 56 (2023) Nr. 11, pp. 2602 - 2620.e10Online Full Text: dx.doi.org/
-
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized TrialIn: Clinical Cancer Research Vol. 29 (2023) Nr. 17, pp. 3313 - 3319Online Full Text: dx.doi.org/ (Open Access)
-
Transcriptional reprogramming by mutated IRF4 in lymphomaIn: Nature Communications Vol. 14 (2023) Nr. 1, 6947Online Full Text: dx.doi.org/ (Open Access)
-
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotranspositionIn: Nature Genetics Vol. 52 (2023) Nr. 3, pp. 306 - 319Online Full Text: dx.doi.org/ (Open Access)
-
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer : a consensus recommendation from the EORTC Imaging and Breast Cancer GroupsIn: The Lancet Oncology Vol. 24 (2023) Nr. 8, pp. e331 - e343Online Full Text: dx.doi.org/
-
HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistanceIn: Clinical Cancer Research Vol. 29 (2023) Nr. 15, pp. 2894 - 2907Online Full Text: dx.doi.org/
-
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma : An international collaborative analysisIn: Leukemia Vol. 37 (2023) Nr. 7, pp. 1511 - 1520Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction: Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesisIn: Nature Communications Vol. 14 (2023) Nr. 1, pp. 2675Online Full Text: dx.doi.org/ (Open Access)
-
Circulating tumor DNA analysis of the phase III VOYAGER trial : KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenibIn: Annals of Oncology Vol. 34 (2023) Nr. 7, pp. 615 - 625Online Full Text: dx.doi.org/
-
Health-related quality of life and pain outcomes with [¹⁷⁷Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION) : a multicentre, open-label, randomised, phase 3 trialIn: The Lancet Oncology Vol. 24 (2023) Nr. 6, pp. 597 - 610Online Full Text: dx.doi.org/
-
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responsesIn: Immunity Vol. 56 (2023) Nr. 6, pp. 1341 - 1358.e11Online Full Text: dx.doi.org/ (Open Access)
-
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomasIn: Neuro-Oncology Vol. 25 (2023) Nr. 9, pp. 1721 - 1723Online Full Text: dx.doi.org/ (Open Access)
-
N1 versus N2 and PMN-MDSC : A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncologyIn: Immunological Reviews Vol. 314 (2023) Nr. 1, pp. 250 - 279Online Full Text: dx.doi.org/ (Open Access)
-
Next generation radiotheranostics promoting precision medicineIn: Annals of Oncology Vol. 34 (2023) Nr. 6, pp. 507 - 519Online Full Text: dx.doi.org/
-
Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesisIn: Nature Communications Vol. 14 (2023) Nr. 1, 2275Online Full Text: dx.doi.org/ (Open Access)
-
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunityIn: Cancer Cell Vol. 41 (2023) Nr. 7, pp. 1207 - 1221.e12Online Full Text: dx.doi.org/ (Open Access)
-
The German Network for Personalized Medicine to enhance patient care and translational researchIn: Nature Medicine Vol. 29 (2023) Nr. 6, pp. 1298 - 1301Online Full Text: dx.doi.org/
-
Neoadjuvant immunotherapy for melanoma is now ready for clinical practiceIn: Nature Medicine Vol. 29 (2023) Nr. 6, pp. 1310 - 1312Online Full Text: dx.doi.org/
-
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantationIn: Blood Vol. 141 (2023) Nr. 23, pp. 2901 - 2911Online Full Text: dx.doi.org/
-
The transcriptional and regulatory identity of erythropoietin producing cellsIn: Nature Medicine Vol. 29 (2023) Nr. 5, pp. 1191 - 1200Online Full Text: dx.doi.org/
-
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancerIn: Gut Vol. 72 (2023) Nr. 6, pp. 1174 - 1185Online Full Text: dx.doi.org/
-
Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial TherapyIn: Cancer Research Vol. 83 (2023) Nr. 8, pp. 1315 - 1328Online Full Text: dx.doi.org/ (Open Access)
-
Active Remodeling of Capillary Endothelium via Cancer Cell-Derived MMP9 Promotes Metastatic Brain ColonizationIn: Cancer Research Vol. 83 (2023) Nr. 8, pp. 1299 - 1314Online Full Text: dx.doi.org/ (Open Access)
-
The repertoire of mutational signatures in human cancerIn: Nature Vol. 578 (2023) Nr. 7793, pp. 94 - 101Online Full Text: dx.doi.org/ (Open Access)
-
Optimizing platelet transfusion through a personalized deep learning risk assessment system for demand managementIn: Blood Vol. 142 (2023) Nr. 26, pp. 2315 - 2326Online Full Text: dx.doi.org/
-
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer GrowthIn: Clinical Cancer Research Vol. 29 (2023) Nr. 6, pp. 1137 - 1154Online Full Text: dx.doi.org/
-
Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma : follow-up and survival outcomes of a single-arm, multicentre, phase 2 studyIn: The Lancet Oncology Vol. 24 (2023) Nr. 11, pp. 1196 - 1205Online Full Text: dx.doi.org/
-
Patterns of somatic structural variation in human cancer genomesIn: Nature Vol. 578 (2023) Nr. 7793, pp. 112 - 121Online Full Text: dx.doi.org/
-
Genomic basis for RNA alterations in cancerIn: Nature Vol. 578 (2023) Nr. 7793, pp. 129 - 136Online Full Text: dx.doi.org/
-
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancerIn: Nature Vol. 615 (2023) Nr. 7950, pp. 168 - 174Online Full Text: dx.doi.org/ (Open Access)
-
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancerIn: Nature Genetics Vol. 52 (2023) Nr. 3, pp. 294 - 305Online Full Text: dx.doi.org/ (Open Access)
-
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patientsIn: Nature Communications Vol. 14 (2023) Nr. 1, 2835Online Full Text: dx.doi.org/ (Open Access)
-
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progressionIn: Neuro-Oncology Vol. 25 (2023) Nr. 12, pp. 2150 - 2162Online Full Text: dx.doi.org/
-
Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotypeIn: Gut Vol. 72 (2023) Nr. 3, pp. 522 - 534Online Full Text: dx.doi.org/ (Open Access)
-
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identificationIn: Nature Communications Vol. 14 (2023) Nr. 1, pp. 4632Online Full Text: dx.doi.org/ (Open Access)
-
Resting natural killer cell homeostasis relies on tryptophan/NAD⁺ metabolism and HIF-1αIn: EMBO Reports (2023) e56156Online Full Text: dx.doi.org/ (Open Access)
-
The landscape of viral associations in human cancersIn: Nature Genetics (2023) Nr. 52, pp. 320 - 330Online Full Text: dx.doi.org/ (Open Access)
-
Immunotherapy targeting plasma ASM is protective in a mouse model of Alzheimer’s diseaseIn: Nature Communications Vol. 14 (2023) Nr. 1, 1631Online Full Text: dx.doi.org/ (Open Access)
-
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic CancerIn: The New England Journal of Medicine Vol. 388 (2023) Nr. 1, pp. 33 - 43Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction: Pan-cancer analysis of whole genomesIn: Nature Vol. 614 (2023) Nr. 7948, pp. E39Online Full Text: dx.doi.org/ (Open Access)
-
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG¹²C mutation : a randomised, open-label, phase 3 trialIn: Lancet Vol. 401 (2023) Nr. 10378, pp. 733 - 746Online Full Text: dx.doi.org/
-
Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophyIn: Acta Neuropathologica Vol. 145 (2023) Nr. 5, pp. 611 - 635Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterationsIn: Nature Communications Vol. 13 (2022) 7572Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : Pathway and network analysis of more than 2500 whole cancer genomesIn: Nature Communications Vol. 13 (2022) 7566Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSigIn: Nature Communications Vol. 13 (2022) 7567Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : Divergent mutational processes distinguish hypoxic and normoxic tumoursIn: Nature Communications Vol. 13 (2022) 7569Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : Combined burden and functional impact tests for cancer driver discovery using DriverPowerIn: Nature Communications Vol. 13 (2022) 7571Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patternsIn: Nature Communications Vol. 13 (2022) 7573Online Full Text: dx.doi.org/ (Open Access)
-
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients with Resectable or Borderline Resectable Disease (COMM-PACT-RB) : A Systematic Review and Delphi Consensus StatementIn: JAMA Oncology Vol. 8 (2022) Nr. 6, pp. 929 - 937Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations : Results from a Multi-institutional European Retrospective StudyIn: Clinical Cancer Research Vol. 28 (2022) Nr. 8, pp. 1672 - 1679Online Full Text: dx.doi.org/ (Open Access)
-
ACKR3 regulates platelet activation and ischemia-reperfusion tissue injuryIn: Nature Communications Vol. 13 (2022) Nr. 1, 1823Online Full Text: dx.doi.org/ (Open Access)
-
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716) : distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trialIn: The Lancet Oncology Vol. 23 (2022) Nr. 11, pp. 1378 - 1388Online Full Text: dx.doi.org/
-
Haplo-PtCy : Adjusting the HLA barrierIn: Blood Vol. 139 (2022) Nr. 10, pp. 1431 - 1433Online Full Text: dx.doi.org/ (Open Access)
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestriesIn: Nature Vol. 612 (2022) Nr. 7938, pp. E7Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : Integrative pathway enrichment analysis of multivariate omics dataIn: Nature Communications Vol. 13 (2022) 7570Online Full Text: dx.doi.org/ (Open Access)
-
Cell-intrinsic ceramides determine T cell function during melanoma progressionIn: eLife Vol. 11 (2022) e83073Online Full Text: dx.doi.org/ (Open Access)
-
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignanciesIn: Blood Vol. 140 (2022) Nr. 20, pp. 2113 - 2126Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : Inferring structural variant cancer cell fractionIn: Nature Communications Vol. 13 (2022) 7568Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction : Genomic footprints of activated telomere maintenance mechanisms in cancerIn: Nature Communications Vol. 13 (2022) 7574Online Full Text: dx.doi.org/ (Open Access)
-
B cell expansion hinders the stroma-epithelium regenerative cross talk during mucosal healingIn: Immunity Vol. 55 (2022) Nr. 12, pp. 2336 - 2351.e12Online Full Text: dx.doi.org/ (Open Access)
-
Persister state-directed transitioning and vulnerability in melanoma
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Nature Communications Vol. 13 (2022) Nr. 1, pp. 35 - 36 -
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute LeukemiaIn: Clinical Cancer Research Vol. 28 (2022) Nr. 5, pp. 870 - 881Online Full Text: dx.doi.org/ (Open Access)
-
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaIn: Blood Vol. 139 (2022) Nr. 4, pp. 538 - 553Online Full Text: dx.doi.org/ (Open Access)
-
CTLA-4 Blockade Resistance after Relatlimab and NivolumabIn: The New England Journal of Medicine Vol. 386 (2022) Nr. 17, pp. 1668 - 1669Online Full Text: dx.doi.org/ (Open Access)
-
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesIn: Clinical Cancer Research Vol. 28 (2022) Nr. 19, pp. 4346 - 4353Online Full Text: dx.doi.org/ (Open Access)
-
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm StudyIn: Clinical Cancer Research Vol. 28 (2022) Nr. 19, pp. 4194 - 4202Online Full Text: dx.doi.org/ (Open Access)
-
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : A post-hoc analysis of the PETAL trialIn: Leukemia Vol. 36 (2022) Nr. 12, pp. 2845 - 2852Online Full Text: dx.doi.org/ (Open Access)
-
Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With CancerIn: JAMA Oncology Vol. 8 (2022) Nr. 12, pp. 1830 - 1839Online Full Text: dx.doi.org/
-
Stroke genetics informs drug discovery and risk prediction across ancestriesIn: Nature Vol. 611 (2022) Nr. 7934, pp. 115 - 123Online Full Text: dx.doi.org/ (Open Access)
-
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : Final results of a randomised, double-blind, phase 2 trialIn: Lancet Vol. 400 (2022) Nr. 10358, pp. 1117 - 1129Online Full Text: dx.doi.org/
-
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancersIn: Annals of Oncology Vol. 33 (2022) Nr. 11, pp. 1186 - 1199Online Full Text: dx.doi.org/ (Open Access)
-
The acid ceramidase/ceramide axis controls parasitemia in Plasmodium yoelii-infected mice by regulating erythropoiesisIn: eLife Vol. 11 (2022) e77975Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
The alarmin interleukin-1α triggers secondary degeneration through reactive astrocytes and endothelium after spinal cord injuryIn: Nature Communications Vol. 13 (2022) Nr. 1, 5786Online Full Text: dx.doi.org/ (Open Access)
-
MCU controls melanoma progression through a redox-controlled phenotype switchIn: EMBO Reports Vol. 23 (2022) Nr. 11, e54746Online Full Text: dx.doi.org/ (Open Access)
-
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphomaIn: Blood Vol. 140 (2022) Nr. 10, pp. 1119 - 1131Online Full Text: dx.doi.org/ (Open Access)
-
The RUHR Heart Failure Network : Improved heart failure care in a metropolitan areaIn: European Heart Journal Vol. 43 (2022) Nr. 45, pp. 4675 - 4676Online Full Text: dx.doi.org/ (Open Access)
-
3D structure and in situ arrangements of CatSper channel in the sperm flagellumIn: Nature Communications Vol. 13 (2022) Nr. 1, 3439Online Full Text: dx.doi.org/ (Open Access)
-
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignanciesIn: Blood Vol. 139 (2022) Nr. 25, pp. 3617 - 3629Online Full Text: dx.doi.org/ (Open Access)
-
Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma : Results from a Proof-of-Concept, Phase Ib StudyIn: Clinical Cancer Research Vol. 28 (2022) Nr. 6, pp. 1087 - 1097Online Full Text: dx.doi.org/ (Open Access)
-
A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantationIn: Blood Vol. 140 (2022) Nr. 6, pp. 659 - 663Online Full Text: dx.doi.org/ (Open Access)
-
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell TransplantationIn: Clinical Cancer Research Vol. 28 (2022) Nr. 5, pp. 1004 - 1012Online Full Text: dx.doi.org/ (Open Access)
-
During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodesIn: Cell Reports Vol. 40 (2022) Nr. 7, 111171Online Full Text: dx.doi.org/ (Open Access)
-
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trialIn: Nature Medicine Vol. 28 (2022) Nr. 8, pp. 1640 - 1645Online Full Text: dx.doi.org/ (Open Access)
-
C11orf94/Frey is a key regulator for male fertility by controlling Izumo1 complex assemblyIn: Science Advances Vol. 8 (2022) Nr. 32, eabo6049Online Full Text: dx.doi.org/ (Open Access)
-
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignanciesIn: European Heart Journal Vol. 43 (2022) Nr. 20, pp. 1928 - 1940Online Full Text: dx.doi.org/ (Open Access)
-
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)In: Annals of Oncology Vol. 33 (2022) Nr. 6, pp. 602 - 615Online Full Text: dx.doi.org/ (Open Access)
-
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyIn: European Heart Journal Vol. 43 (2022) Nr. 4, pp. 316 - 329Online Full Text: dx.doi.org/
-
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor MicroenvironmentIn: Cancer Research Vol. 82 (2022) Nr. 2, pp. 264 - 277Online Full Text: dx.doi.org/ (Open Access)
-
Stroke induces disease-specific myeloid cells in the brain parenchyma and piaIn: Nature Communications Vol. 13 (2022) Nr. 1, 945Online Full Text: dx.doi.org/ (Open Access)
-
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumorsIn: Nature Communications Vol. 13 (2022) Nr. 1, 4061Online Full Text: dx.doi.org/ (Open Access)
-
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant MelanomaIn: Clinical Cancer Research Vol. 28 (2022) Nr. 14, pp. 3002 - 3010Online Full Text: dx.doi.org/ (Open Access)
-
Cellular plasticity upon proton irradiation determines tumor cell radiosensitivityIn: Cell Reports Vol. 38 (2022) Nr. 8, 110422Online Full Text: dx.doi.org/ (Open Access)
-
Gold Nanorods Induce Endoplasmic Reticulum Stress and Autocrine Inflammatory Activation in Human NeutrophilsIn: ACS Nano Vol. 16 (2022) Nr. 7, pp. 11011 - 11026Online Full Text: dx.doi.org/
-
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell CarcinomaIn: The New England Journal of Medicine Vol. 387 (2022) Nr. 17, pp. 1557 - 1568Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716) : a randomised, double-blind, phase 3 trialIn: Lancet Vol. 399 (2022) Nr. 10336, pp. 1718 - 1729Online Full Text: dx.doi.org/
-
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expressionIn: Nature Communications Vol. 13 (2022) Nr. 1, 156Online Full Text: dx.doi.org/ (Open Access)
-
DJ-1 depletion prevents immunoaging in T-cell compartmentsIn: EMBO Reports Vol. 23 (2022) Nr. 3, e53302Online Full Text: dx.doi.org/ (Open Access)
-
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced MelanomaIn: The New England Journal of Medicine Vol. 386 (2022) Nr. 1, pp. 24 - 34Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality : Results from 49,089 COVID-19 inpatientsIn: Molecular Psychiatry Vol. 27 (2022) Nr. 3, pp. 1278 - 1280Online Full Text: dx.doi.org/ (Open Access)
-
Gastrointestinal stromal tumours : ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-upIn: Annals of Oncology Vol. 33 (2022) Nr. 1, pp. 20 - 33Online Full Text: dx.doi.org/ (Open Access)
-
Preneoplastic somatic mutations including MYD88L²⁶⁵P in lymphoplasmacytic lymphomaIn: Science Advances Vol. 8 (2022) Nr. 3, eabl4644Online Full Text: dx.doi.org/ (Open Access)
-
Imaging innate immunity*In: Immunological Reviews Vol. 306 (2022) Nr. 1, pp. 293 - 303Online Full Text: dx.doi.org/ (Open Access)
-
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma : Interim analysis of the GMMG-CONCEPT trialIn: Leukemia Vol. 36 (2022) Nr. 3, pp. 885 - 888Online Full Text: dx.doi.org/ (Open Access)
-
The acid sphingomyelinase/ceramide system in COVID-19In: Molecular Psychiatry Vol. 27 (2022) Nr. 1, pp. 307 - 314Online Full Text: dx.doi.org/ (Open Access)
-
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesIn: Cancer Discovery Vol. 2 (2021) Nr. 1, pp. 70 - 91Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS StudyIn: Clinical Cancer Research Vol. 27 (2021) Nr. 23, pp. 6333 - 6342Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Bone sarcomas : ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-upIn: Annals of Oncology Vol. 32 (2021) Nr. 12, pp. 1520 - 1536Online Full Text: dx.doi.org/ (Open Access)
-
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersIn: Cancer Discovery Vol. 11 (2021) Nr. 11, pp. 2780 - 2795Online Full Text: dx.doi.org/ (Open Access)
-
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumoursIn: Annals of Oncology Vol. 32 (2021) Nr. 11, pp. 1332 - 1347Online Full Text: dx.doi.org/ (Open Access)
-
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomasIn: Blood Vol. 137 (2021) Nr. 20, pp. 2785 - 2799Online Full Text: dx.doi.org/ (Open Access)
-
Mapping the human genetic architecture of COVID-19In: Nature Vol. 600 (2021) pp. 472 - 477Online Full Text: dx.doi.org/ (Open Access)
-
Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasisIn: Cell Reports Vol. 37 (2021) Nr. 8, 110056Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Coating of cochlear implant electrodes with bioactive DNA-loaded calcium phosphate nanoparticles for the local transfection of stimulatory proteinsIn: Biomaterials Vol. 276 (2021)Online Full Text: dx.doi.org/
-
Agony of choice : How anesthetics affect the composition and function of extracellular vesiclesIn: Advanced Drug Delivery Reviews Vol. 175 (2021) 113813Online Full Text: dx.doi.org/
-
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate CancerIn: The New England Journal of Medicine Vol. 385 (2021) pp. 1091 - 1103Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Mutations in the IFNγ-JAK-STAT pathway causing resistance to immune checkpoint inhibitors in melanoma increase sensitivity to oncolytic virus treatmentIn: Clinical Cancer Research Vol. 27 (2021) Nr. 12, pp. 3432 - 3442Online Full Text: dx.doi.org/ (Open Access)
-
Neutrophils self-limit swarming to contain bacterial growth in vivoIn: Science Vol. 372 (2021) Nr. 6548,Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defectsIn: Molecular Psychiatry Vol. 26 (2021) Nr. 12, pp. 7403 - 7416Online Full Text: dx.doi.org/ (Open Access)
-
Multiple Hepatic and Pulmonary Tumors Combined with Bilateral Adrenal Masses in a Young Woman with von Hippel–Lindau DiseaseIn: Gastroenterology Vol. 161 (2021) Nr. 4, pp. e1 - e4Online Full Text: dx.doi.org/ (Open Access)
-
PLK1-dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV-infected miceIn: EMBO Reports (2021) e53007Online Full Text: dx.doi.org/ (Open Access)
-
Cellular model system to dissect the isoform-selectivity of Akt inhibitorsIn: Nature Communications Vol. 12 (2021) Nr. 1, 5297Online Full Text: dx.doi.org/ (Open Access)
-
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-IIn: Nature Communications Vol. 12 (2021) Nr. 1, 5505Online Full Text: dx.doi.org/ (Open Access)
-
Diagnostic Accuracy of ⁶⁸Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging TrialIn: JAMA Oncology Vol. 7 (2021) Nr. 11, pp. 1635 - 1642Online Full Text: dx.doi.org/ (Open Access)
-
TRIP6 functions in brain ciliogenesisIn: Nature Communications Vol. 12 (2021) Nr. 1, 5887Online Full Text: dx.doi.org/ (Open Access)
-
Metabolic requirements of NK cells during the acute response against retroviral infectionIn: Nature Communications Vol. 12 (2021) Nr. 1, 5376Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19 : Current evidence and potential mechanismsIn: Molecular Psychiatry Vol. 26 (2021) Nr. 12, pp. 7098 - 7099Online Full Text: dx.doi.org/ (Open Access)
-
Scaled preparation of extracellular vesicles from conditioned mediaIn: Advanced Drug Delivery Reviews Vol. 177 (2021) 113940Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
NK cells in hypoxic skin mediate a trade-off between wound healing and antibacterial defenceIn: Nature Communications Vol. 12 (2021) Nr. 1, 4700Online Full Text: dx.doi.org/ (Open Access)
-
Nomograms to predict outcomes after ¹⁷⁷Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer : An international, multicentre, retrospective studyIn: The Lancet Oncology Vol. 22 (2021) Nr. 8, pp. 1115 - 1125Online Full Text: dx.doi.org/ (Open Access)
-
GPR15 facilitates recruitment of regulatory T cells to promote colorectal cancerIn: Cancer Research Vol. 81 (2021) Nr. 11, pp. 2970 - 2982Online Full Text: dx.doi.org/; Online Full Text: dx.doi.org/ (Open Access)
-
Nuclear receptor coactivator NCOA3 regulates UV radiation⇓induced DNA damage and melanoma susceptibilityIn: Cancer Research Vol. 81 (2021) Nr. 11, pp. 2956 - 2969Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialIn: The Lancet Oncology Vol. 22 (2021) Nr. 5, pp. 655 - 664Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Phase I assessment of safety and therapeutic activity of BAY1436032 in patients with IDH1-mutant solid tumorsIn: Clinical Cancer Research Vol. 27 (2021) Nr. 10, pp. 2723 - 2733Online Full Text: dx.doi.org/ (Open Access)
-
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trialIn: The Lancet Oncology Vol. 22 (2021) Nr. 5, pp. 643 - 654Online Full Text: dx.doi.org/
-
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib : A clinical validation studyIn: The Lancet Oncology Vol. 22 (2021) Nr. 3, pp. 370 - 380Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Corrigendum to “Inhibiting fibroblast growth factor receptors in cancer – The next generation”In: Annals of Oncology Vol. 32 (2021) Nr. 1, pp. 126Online Full Text: dx.doi.org/ (Open Access)
-
The West German heart and vascular center at university medicine EssenIn: European Heart Journal Vol. 42 (2021) Nr. 10, pp. 963 - 964Online Full Text: dx.doi.org/ (Open Access)
-
New players in the regulation of DNA-PK activity : Survivin joins the crowdIn: Cancer Research Vol. 81 (2021) Nr. 9, pp. 2270 - 2271Online Full Text: dx.doi.org/ (Open Access)
-
A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargosIn: Advanced Drug Delivery Reviews Vol. 173 (2021) pp. 479 - 491Online Full Text: dx.doi.org/ (Open Access)
-
Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomasIn: Leukemia Vol. 35 (2021) pp. 2002 - 2016Online Full Text: dx.doi.org/ (Open Access)
-
Bacterial protein domains with a novel Ig-like fold target human CEACAM receptorsIn: The EMBO Journal Vol. 40 (2021) Nr. 7, pp. e106103Online Full Text: dx.doi.org/ (Open Access)
-
Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E StainsIn: Clinical Cancer Research Vol. 27 (2021) Nr. 4, pp. 1131 - 1138Online Full Text: dx.doi.org/ (Open Access)
-
Antibody-guided in vivo imaging of Aspergillus fumigatus lung infections during antifungal azole treatmentIn: Nature Communications Vol. 12 (2021) Nr. 1, pp. 1707Online Full Text: dx.doi.org/ (Open Access)
-
Altered mitochondria functionality defines a metastatic cell state in lung cancer and creates an exploitable vulnerabilityIn: Cancer Research Vol. 81 (2021) Nr. 3, pp. 567 - 579Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
FAST : a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinomaIn: Annals of Oncology Vol. 32 (2021) Nr. 5, pp. 609 - 619Online Full Text: dx.doi.org/ (Open Access)
-
Nuclear medicine theranostics comes of ageIn: The Lancet Oncology Vol. 22 (2021) Nr. 11, pp. 1497 - 1498Online Full Text: dx.doi.org/
-
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal FluidIn: Immunity Vol. 54 (2021) Nr. 1, pp. 164Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Protein Signatures of NK Cell–Mediated Melanoma Killing Predict Response to ImmunotherapiesIn: Cancer Research Vol. 81 (2021) Nr. 21, pp. 5540 - 5554Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Sugar-modified B-cell receptors in DLBCLIn: Blood Vol. 138 (2021) Nr. 17, pp. 1512 - 1514Online Full Text: dx.doi.org/ (Open Access)
-
PI3KC2β inactivation stabilizes VE‐cadherin junctions and preserves vascular integrityIn: EMBO Reports (2021) pp. e51299Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113) : a multicentre, randomised, phase 2 trialIn: The Lancet Gastroenterology & Hepatology Vol. 6 (2021) Nr. 2, pp. 128 - 138Online Full Text: dx.doi.org/
-
Soft tissue and visceral sarcomas : ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆In: Annals of Oncology Vol. 32 (2021) Nr. 11, 1348-1365Online Full Text: dx.doi.org/ (Open Access)
-
Molecular biology of Hodgkin lymphomaIn: Leukemia Vol. 35 (2021) Nr. 4, pp. 968 - 981Online Full Text: dx.doi.org/ (Open Access)
-
Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DMIn: Blood Vol. 137 (2021) Nr. 7, pp. 923 - 928Online Full Text: dx.doi.org/ (Open Access)
-
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW) : a multi-cohort, open-label, registrational, phase 1/2 studyIn: The Lancet Diabetes and Endocrinology Vol. 9 (2021) Nr. 8, pp. 491 - 501Online Full Text: dx.doi.org/
-
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus TrametinibIn: Clinical Cancer Research Vol. 27 (2021) Nr. 16, pp. 4500 - 4510Online Full Text: dx.doi.org/ (Open Access)
-
Sotorasib for Lung Cancers with KRAS p.G12C MutationIn: The New England Journal of Medicine Vol. 384 (2021) Nr. 25, pp. 2371 - 2381Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypesIn: Nature Communications Vol. 12 (2021) Nr. 1, pp. 2048Online Full Text: dx.doi.org/ (Open Access)
-
PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman PrimatesIn: Clinical Cancer Research Vol. 27 (2021) Nr. 7, pp. 2050 - 2060Online Full Text: dx.doi.org/; Online Full Text: dx.doi.org/ (Open Access)
-
Resistance to avapritinib in pdgfra-driven gist is caused by secondary mutations in the pdgfra kinase domainIn: Cancer Discovery Vol. 11 (2021) Nr. 1, pp. 108 - 125Online Full Text: dx.doi.org/ (Open Access)
-
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19In: Nature Communications Vol. 12 (2021) Nr. 1, pp. 1813Online Full Text: dx.doi.org/ (Open Access)
-
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1In: Blood Vol. 137 (2021) Nr. 5, pp. 646 - 660Online Full Text: dx.doi.org/ (Open Access)
-
Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progressionIn: Nature Communications Vol. 12 (2021) Nr. 1, 3895Online Full Text: dx.doi.org/ (Open Access)
-
Functional Comparison of Interferon-α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon-α and Interferon-γ SignalingIn: Hepatology Vol. 73 (2021) Nr. 2, pp. 486 - 502Online Full Text: dx.doi.org/
-
Leadership challenges defusedIn: Science Vol. 371 (2021) Nr. 6533, pp. 1070Online Full Text: dx.doi.org/ (Open Access)
-
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasionIn: Nature Genetics Vol. 53 (2021) Nr. 3, pp. 332 - 341Online Full Text: dx.doi.org/; Online Full Text: dx.doi.org/ (Open Access)
-
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache : A multicentre, double-blind, randomised controlled trialIn: The Lancet Neurology Vol. 20 (2021) Nr. 1, pp. 29 - 37Online Full Text: dx.doi.org/
-
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapyIn: Nature Communications Vol. 12 (2021) Nr. 1, pp. 346Online Full Text: dx.doi.org/ (Open Access)
-
Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemiaIn: Leukemia Vol. 35 (2021) Nr. 2, pp. 585 - 594Online Full Text: dx.doi.org/
-
UMI or not UMI, that is the question for scRNA-seq zero-inflationIn: Nature Biotechnology Vol. 39 (2021) Nr. 2, pp. 158 - 159Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Association of BRAF V600E/K Mutation Status and Prior BRAF/MEK Inhibition with Pembrolizumab Outcomes in Advanced Melanoma : Pooled Analysis of 3 Clinical TrialsIn: JAMA Oncology Vol. 6 (2020) Nr. 8, pp. 1256 - 1264Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaIn: Nature Medicine Vol. 26 (2020) Nr. 7, pp. 1147Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samplesIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 6232Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanomaIn: Nature Vol. 580 (2020) Nr. 7801, pp. E1Online Full Text: dx.doi.org/ (Open Access)
-
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR) : A multicentre, open-label, phase 1 trialIn: The Lancet Oncology Vol. 21 (2020) Nr. 7, pp. 935 - 946Online Full Text: dx.doi.org/
-
Cancer cells stock up in lymph vessels to surviveIn: Nature Vol. 585 (2020) Nr. 7823, pp. 36 - 37Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Co-option of Neutrophil Fates by Tissue EnvironmentsIn: Cell Vol. 183 (2020) Nr. 5, pp. 1282 - 1297.e18Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma : safety run-in and biomarker cohorts of COMBI-iIn: Nature Medicine Vol. 26 (2020) Nr. 10, pp. 1557 - 1563Online Full Text: dx.doi.org/
-
Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypesIn: Blood Vol. 136 (2020) Nr. 12, pp. 1419 - 1432Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
A clinical perspective on the 2019 ESC/EAS guidelines for the management of dyslipidaemias: PCSK-9 inhibitors for all?In: European Heart Journal Vol. 41 (2020) Nr. 24, pp. 2331Online Full Text: dx.doi.org/
-
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III MelanomaIn: The New England Journal of Medicine Vol. 383 (2020) Nr. 12, pp. 1139 - 1148Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Genomic footprints of activated telomere maintenance mechanisms in cancerIn: Nature Communications Vol. 11 (2020) 733Online Full Text: dx.doi.org/ (Open Access)
-
Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumoursIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 1335Online Full Text: dx.doi.org/ (Open Access)
-
Durable and controlled depletion of neutrophils in miceIn: Nature Communications Vol. 11 (2020) pp. 2762Online Full Text: dx.doi.org/ (Open Access)
-
Heterobifunctional Rotaxanes for Asymmetric CatalysisIn: Angewandte Chemie International Edition Vol. 59 (2020) Nr. 13, pp. 5102 - 5107Online Full Text: dx.doi.org/ (Open Access)
-
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterationsIn: Nature Communications Vol. 11 (2020) 736Online Full Text: dx.doi.org/ (Open Access)
-
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patternsIn: Nature Communications Vol. 11 (2020) 728Online Full Text: dx.doi.org/ (Open Access)
-
Anemia increases long-term mortality in patients undergoing conventional coronary angiography – the ECAT registry
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,In: European Heart Journal Vol. 41 (2020) Nr. Supplement_2, pp. 1508Online Full Text: dx.doi.org/ -
Combined burden and functional impact tests for cancer driver discovery using DriverPowerIn: Nature Communications Vol. 11 (2020) 734Online Full Text: dx.doi.org/ (Open Access)
-
Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK PathwayIn: Cancer Research Vol. 80 (2020) Nr. 21, pp. 4655 - 4667Online Full Text: dx.doi.org/ (Open Access)
-
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors failsIn: Blood Vol. 135 (2020) Nr. 16, pp. 1386 - 1395Online Full Text: dx.doi.org/ (Open Access)
-
Inferring structural variant cancer cell fractionIn: Nature Communications Vol. 11 (2020) 730Online Full Text: dx.doi.org/ (Open Access)
-
Divergent mutational processes distinguish hypoxic and normoxic tumoursIn: Nature Communications Vol. 11 (2020) 737Online Full Text: dx.doi.org/ (Open Access)
-
Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to ImmunotherapyIn: Clinical Cancer Research Vol. 26 (2020) Nr. 21, pp. 5638 - 5645Online Full Text: dx.doi.org/ (Open Access)
-
Integrative pathway enrichment analysis of multivariate omics dataIn: Nature Communications Vol. 11 (2020) 735Online Full Text: dx.doi.org/ (Open Access)
-
Integrated molecular drivers coordinate biological and clinical states in melanomaIn: Nature Genetics Vol. 52 (2020) Nr. 12, pp. 1373 - 1383Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Survival Outcomes Associated with 3 Years vs 1 Year of Adjuvant Imatinib for Patients with High-Risk Gastrointestinal Stromal Tumors : An Analysis of a Randomized Clinical Trial after 10-Year Follow-upIn: JAMA Oncology Vol. 6 (2020) Nr. 8, pp. 1241 - 1246Online Full Text: dx.doi.org/ (Open Access)
-
Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA HeterogeneityIn: Clinical Cancer Research Vol. 26 (2020) Nr. 12, pp. 2946 - 2955Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterationsIn: Acta Neuropathologica Vol. 139 (2020) Nr. 2, pp. 243 - 257Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Radiotheranostics : A roadmap for future developmentIn: The Lancet Oncology Vol. 21 (2020) Nr. 3, pp. e146 - e156Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Nusinersen in adults with 5q spinal muscular atrophy : A non-interventional, multicentre, observational cohort studyIn: The Lancet Neurology Vol. 19 (2020) Nr. 4, pp. 317 - 325Online Full Text: dx.doi.org/
-
Pathway and network analysis of more than 2500 whole cancer genomesIn: Nature Communications Vol. 11 (2020) 729Online Full Text: dx.doi.org/ (Open Access)
-
Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healingIn: Gut Vol. 69 (2020) pp. 252 - 263Online Full Text: dx.doi.org/
-
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke : A multicentre, double-blind, randomised, placebo-controlled trialIn: The Lancet Neurology Vol. 19 (2020) Nr. 3, pp. 226 - 233Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Pan-cancer analysis of whole genomesIn: Nature Vol. 578 (2020) Nr. 7793, pp. 82 - 93Online Full Text: dx.doi.org/ (Open Access)
-
Rationale for Immune Checkpoint Inhibitors plus Targeted Therapy in Metastatic Melanoma : A ReviewIn: JAMA Oncology Vol. 6 (2020) Nr. 12, pp. 1957 - 1966Online Full Text: dx.doi.org/
-
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv⁶⁰⁰ mutation–positive melanoma receiving adjuvant vemurafenibIn: Annals of Oncology Vol. 31 (2020) Nr. 1, pp. 153 - 159Online Full Text: dx.doi.org/ (Open Access)
-
Association between Immune-Related Adverse Events and Recurrence-Free Survival among Patients with Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo : A Secondary Analysis of a Randomized Clinical TrialIn: JAMA Oncology Vol. 6 (2020) Nr. 4, pp. 519 - 527Online Full Text: dx.doi.org/ (Open Access)
-
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapyIn: The Lancet Oncology Vol. 21 (2020) Nr. 9, pp. e431 - e443Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV⁶⁰⁰-mutant, stage III melanoma (COMBI-AD) : Exploratory biomarker analyses from a randomised, phase 3 trialIn: The Lancet Oncology Vol. 21 (2020) Nr. 3, pp. 358 - 372Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibilityIn: Nature Genetics Vol. 52 (2020) Nr. 5, pp. 494 - 504Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activityIn: Cancer Research Vol. 80 (2020) Nr. 4, pp. 798 - 810Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell CarcinomaIn: Clinical Cancer Research Vol. 26 (2020) Nr. 9, pp. 2257 - 2267Online Full Text: dx.doi.org/ (Open Access)
-
Biochemical evidence for Ku-independent backup pathways of NHEJIn: Nucleic Acids Research Vol. 48 (2020) Nr. 9, pp. 5200Online Full Text: dx.doi.org/ (Open Access)
-
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED) : A randomised, double-blind, placebo-controlled, phase 2 trialIn: Lancet Vol. 395 (2020) Nr. 10236, pp. 1558 - 1568Online Full Text: dx.doi.org/
-
A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus controlIn: Journal of Hepatology Vol. 72 (2020) Nr. 5, pp. 960 - 975Online Full Text: dx.doi.org/ (Open Access)
-
Cemiplimab in locally advanced cutaneous squamous cell carcinoma : results from an open-label, phase 2, single-arm trialIn: The Lancet Oncology Vol. 21 (2020) Nr. 2, pp. 294 - 305Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Dead Cells Induce Innate Anergy via Mertk after Acute Viral InfectionIn: Cell Reports Vol. 30 (2020) Nr. 11, pp. 3671 - 3681.e5Online Full Text: dx.doi.org/ (Open Access)
-
Immunotherapeutic blockade of CD47 inhibitory signaling enhances innate and adaptive immune responses to viral infectionIn: Cell Reports Vol. 31 (2020) Nr. 2, pp. 107494Online Full Text: dx.doi.org/ (Open Access)
-
Involvement of Hus1 in the chain elongation step of DNA replication after exposure to camptothecin or ionizing radiationIn: Nucleic Acids Research Vol. 48 (2020) Nr. 6, pp. 3396Online Full Text: dx.doi.org/ (Open Access)
-
Metabolic heterogeneity confers differences in melanoma metastatic potentialIn: Nature Vol. 577 (2020) Nr. 7788, pp. 115 - 120Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer : Clinical and biomarker results from a phase I trialIn: Annals of Oncology Vol. 31 (2020) Nr. 6, pp. 789 - 797Online Full Text: dx.doi.org/ (Open Access)
-
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSigIn: Nature Communications Vol. 11 (2020) 731Online Full Text: dx.doi.org/ (Open Access)
-
Refining endpoints for stroke recovery trialsIn: The Lancet Neurology Vol. 19 (2020) Nr. 5, pp. 381 - 382Online Full Text: dx.doi.org/ (Open Access)
-
STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosisIn: Gut Vol. 69 (2020) Nr. 7, pp. 1269 - 1282Online Full Text: dx.doi.org/
-
Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanomaIn: Annals of Oncology Vol. 31 (2020) Nr. 1, pp. 144 - 152Online Full Text: dx.doi.org/ (Open Access)
-
Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe diseaseIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 1338Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samplesIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 4748Online Full Text: dx.doi.org/ (Open Access)
-
Sex differences in oncogenic mutational processesIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 4330Online Full Text: dx.doi.org/ (Open Access)
-
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 2465Online Full Text: dx.doi.org/ (Open Access)
-
Cardiac fibroblast activation detected by positron emission tomography/computed tomography as a possible sign of cardiotoxicityIn: European Heart Journal Vol. 41 (2020) Nr. 9, pp. 1060Online Full Text: dx.doi.org/
-
Crizotinib in ROS1 and MET deregulated NSCLC-letterIn: Clinical Cancer Research Vol. 26 (2020) Nr. 7, pp. 1774Online Full Text: dx.doi.org/ (Open Access)
-
The quest for efficient trial designs in precision oncologyIn: The Lancet Oncology Vol. 21 (2020) Nr. 12, pp. 1539 - 1541Online Full Text: dx.doi.org/
-
Lactate released by inflammatory bone marrow neutrophils induces their mobilization via endothelial GPR81 signalingIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 3547Online Full Text: dx.doi.org/ (Open Access)
-
A combined experimental and modelling approach for the Weimberg pathway optimisationIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 1098Online Full Text: dx.doi.org/ (Open Access)
-
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS) : a double-blind, randomised, placebo-controlled, phase 3 trialIn: The Lancet Oncology Vol. 21 (2020) Nr. 7, pp. 923 - 934Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injuryIn: Gut Vol. 69 (2020) Nr. 1, pp. 133 - 145Online Full Text: dx.doi.org/ (Open Access)
-
Strong suppression of gene conversion with increasing DNA double-strand break load delimited by 53BP1 and RAD52In: Nucleic Acids Research Vol. 48 (2020) Nr. 4, pp. 1905 - 1924Online Full Text: dx.doi.org/ (Open Access)
-
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide TherapyIn: Gastroenterology Vol. 158 (2020) Nr. 8, pp. 2180 - 2194Online Full Text: dx.doi.org/ (Open Access)
-
Tertiary lymphoid structures improve immunotherapy and survival in melanomaIn: Nature Vol. 577 (2020) Nr. 7791, pp. 561 - 565Online Full Text: dx.doi.org/
-
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerabilityIn: Nature Communications Vol. 11 (2020) Nr. 1, pp. 4684Online Full Text: dx.doi.org/ (Open Access)
-
Thyroid Hormone TransportersIn: Endocrine Reviews Vol. 41 (2020) Nr. 2, pp. 146 - 201Online Full Text: dx.doi.org/ (Open Access)
-
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms Across Eight Psychiatric DisordersIn: Cell Vol. 179 (2019) Nr. 7, pp. 1469 - 1482.e11.Online Full Text: dx.doi.org/ (Open Access)
-
3D extracellular matrix microenvironment in bioengineered tissue models of primary pediatric and adult brain tumorsIn: Nature Communications Vol. 10 (2019) pp. 4529Online Full Text: dx.doi.org/ (Open Access)
-
Current gaps in sepsis immunology: new opportunities for translational researchIn: The Lancet Infectious Diseases Vol. 19 (2019) Nr. 12, pp. e422 - e436Online Full Text: dx.doi.org/ (Open Access)
-
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaIn: The New England Journal of Medicine Vol. 381 (2019) Nr. 16, pp. 1535 - 1546Online Full Text: dx.doi.org/ (Open Access)
-
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus : the MONO studyIn: Annals of Oncology Vol. 30 (2019) Nr. 9, pp. 1487 - 1495Online Full Text: dx.doi.org/ (Open Access)
-
Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunityIn: FEMS Microbiology Reviews Vol. 43 (2019) Nr. 5, pp. 435 - 456Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosaIn: Nature Genetics Vol. 51 (2019) Nr. 8, pp. 1207 - 1214Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Five-year outcomes with dabrafenib plus trametinib in metastatic melanomaIn: The New England Journal of Medicine Vol. 381 (2019) Nr. 7, pp. 626 - 636Online Full Text: dx.doi.org/ (Open Access)
-
HDAC8 regulates a stress response pathway in melanoma to mediate escape from BRAF inhibitor therapyIn: Cancer Research Vol. 79 (2019) Nr. 11, pp. 2947 - 2961Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Human gastric cancer modelling using organoidsIn: Gut Vol. 68 (2019) Nr. 2, pp. 207 - 217Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphomaIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 1459Online Full Text: dx.doi.org/ (Open Access)
-
Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell deathIn: Nature Vol. 569 (2019) Nr. 7755, pp. 236 - 240Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanomaIn: Nature Medicine Vol. 25 (2019) Nr. 12, pp. 1916 - 1927Online Full Text: dx.doi.org/ (Open Access)
-
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt LymphomaIn: Cancer Research Vol. 79 (2019) Nr. 12, pp. 3125 - 3138Online Full Text: dx.doi.org/ (Open Access)
-
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8⁺ T Cells and Evolve at the Population LevelIn: Gastroenterology Vol. 156 (2019) Nr. 6, pp. 1820 - 1833Online Full Text: dx.doi.org/ (Open Access)
-
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal CancerIn: Cancer Research Vol. 79 (2019) Nr. 9, pp. 2367 - 2378Online Full Text: dx.doi.org/
-
Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infectionIn: Journal of Hepatology Vol. 70 (2019) Nr. 1 Suppl., pp. e81Online Full Text: dx.doi.org/
-
Prostate-specific membrane antigen ligand positron emission tomography in men with nonmetastatic castration-resistant prostate cancerIn: Clinical Cancer Research Vol. 25 (2019) Nr. 24, pp. 7448 - 7454Online Full Text: dx.doi.org/ (Open Access)
-
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN) : a randomised phase 3 trialIn: Lancet Vol. 394 (2019) Nr. 10197, pp. 478 - 487Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Alpelisib Plus Fulvestrant in PIK3CA -Altered and PIK3CA -Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer : A Phase 1b Clinical TrialIn: JAMA Oncology Vol. 5 (2019) Nr. 2, pp. e184475Online Full Text: dx.doi.org/ (Open Access)
-
Publisher Correction: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathwaysIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 299Online Full Text: dx.doi.org/ (Open Access)
-
Microglial cell loss after ischemic stroke favors brain neutrophil accumulationIn: Acta Neuropathologica Vol. 137 (2019) Nr. 2, pp. 321 - 341Online Full Text: dx.doi.org/ (Open Access)
-
Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope ProteinsIn: Cell Reports Vol. 27 (2019) Nr. 7, pp. 2092 - 2104.e10Online Full Text: dx.doi.org/ (Open Access)
-
Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancerIn: Annals of Oncology Vol. 30 (2019) Nr. 4, pp. 655 - 657Online Full Text: dx.doi.org/ (Open Access)
-
Reply [Letter to the Editor: Characterization of CD169+ Macrophages in Liver Regeneration: Tissue Distribution and Fate?]In: Hepatology Vol. 70 (2019) Nr. 3, pp. 1074 - 1075Online Full Text: dx.doi.org/ (Open Access)
-
Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphomaIn: Blood Vol. 134 (2019) Nr. 13, pp. 1072 - 1083Online Full Text: dx.doi.org/ (Open Access)
-
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in MelanomaIn: Cell Reports Vol. 27 (2019) Nr. 12, pp. 3573 - 3586.e7Online Full Text: dx.doi.org/ (Open Access)
-
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive TumorsIn: Cell Vol. 176 (2019) Nr. 3, pp. 505 - 519.e22Online Full Text: dx.doi.org/ (Open Access)
-
Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD) : a randomised, placebo-controlled, phase 3 trialIn: The Lancet Oncology Vol. 20 (2019) Nr. 5, pp. 701 - 710Online Full Text: dx.doi.org/
-
Publisher Correction: Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 2768Online Full Text: dx.doi.org/ (Open Access)
-
Weightlifting unmasks high-risk coronary anomalyIn: European Heart Journal Vol. 40 (2019) Nr. 1, pp. 72Online Full Text: dx.doi.org/ (Open Access)
-
Understanding HDV and HBsAg kinetics during nucleic acid polymer REP 2139 mono-therapy in HBeAg-negative chronic HBV/HDV co-infected patients via mathematical modelingIn: Journal of Hepatology Vol. 70 (2019) Nr. 1 Suppl., pp. e463Online Full Text: dx.doi.org/
-
Defective homologous recombination DNA repair as therapeutic target in advanced chordomaIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 1635Online Full Text: dx.doi.org/ (Open Access)
-
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL) : a multicentre, open-label, randomised, controlled phase II trialIn: Annals of Oncology Vol. 30 (2019) Nr. 2, pp. 317 - 324Online Full Text: dx.doi.org/ (Open Access)
-
Assessment of ⁶⁸Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer : A Prospective Single-Arm Clinical TrialIn: JAMA Oncology Vol. 5 (2019) Nr. 6, pp. 856 - 863Online Full Text: dx.doi.org/ (Open Access)
-
Axon-like protrusions promote small cell lung cancer migration and metastasisIn: eLife Vol. 8 (2019) pp. e50616Online Full Text: dx.doi.org/ (Open Access)
-
Covalent-Allosteric Inhibitors to Achieve Akt Isoform-SelectivityIn: Angewandte Chemie International Edition Vol. 58 (2019) Nr. 52, pp. 18823 - 18829Online Full Text: dx.doi.org/ (Open Access)
-
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines CommitteesIn: Annals of Oncology Vol. 30 (2019) Nr. 11, pp. 1697 - 1727Online Full Text: dx.doi.org/ (Open Access)
-
Melanoma extracellular vesicles generate immunosuppressive myeloid cells by upregulating PD-L1 via TLR4 signalingIn: Cancer Research Vol. 79 (2019) Nr. 18, pp. 4715 - 4728Online Full Text: dx.doi.org/ (Open Access)
-
Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal CancerIn: Immunity Vol. 50 (2019) Nr. 1, pp. 166 - 180.e7Online Full Text: dx.doi.org/ (Open Access)
-
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and MetastasisIn: Cancer Cell Vol. 36 (2019) Nr. 3, pp. 319 - 336.e7Online Full Text: dx.doi.org/ (Open Access)
-
MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearanceIn: Journal of Hepatology Vol. 71 (2019) Nr. 4, pp. 685 - 698Online Full Text: dx.doi.org/
-
Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 2312Online Full Text: dx.doi.org/ (Open Access)
-
Publisher Correction : Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathwaysIn: Nature Communications Vol. 10 (2019) Nr. 1, pp. 299Online Full Text: dx.doi.org/ (Open Access)
-
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantationIn: Nature Medicine Vol. 25 (2019) Nr. 4, pp. 603 - 611Online Full Text: dx.doi.org/ (Open Access)
-
Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression : a phase 1 dose-escalation and dose-expansion studyIn: The Lancet Oncology Vol. 20 (2019) Nr. 10, pp. 1454 - 1466Online Full Text: dx.doi.org/
-
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4) : A randomised, phase 2/3 trialIn: Lancet Vol. 393 (2019) Nr. 10184, pp. 1948 - 1957Online Full Text: dx.doi.org/
-
Survival Outcomes in Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma Treated with Nivolumab Therapy : Three-Year Follow-up of a Randomized Phase 3 TrialIn: JAMA Oncology Vol. 5 (2019) Nr. 2, pp. 187 - 194Online Full Text: dx.doi.org/ (Open Access)
-
The intramembrane protease SPPL2c promotes male germ cell development by cleaving phospholambanIn: EMBO Reports Vol. 20 (2019) Nr. 3, pp. e46449Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Treatment in metastatic melanoma : Time to re-thinkIn: Annals of Oncology Vol. 30 (2019) Nr. 4, pp. 501 - 503Online Full Text: dx.doi.org/ (Open Access)
-
Adverse events (AEs) over time in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (Pbo) in the COMBI-AD trialIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii446Online Full Text: dx.doi.org/ (Open Access)
-
Adjuvant melanoma therapy with new drugs : Should physicians continue to focus on metastatic disease or use it earlier in primary melanoma?In: The Lancet Oncology Vol. 19 (2018) Nr. 12, pp. e720 - e725Online Full Text: dx.doi.org/
-
Bone sarcomas : ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 4, pp. iv79 - iv95Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
A distinct oncogenerative multinucleated cancer cell serves as a source of stemness and tumor heterogeneityIn: Cancer Research Vol. 78 (2018) Nr. 9, pp. 2318 - 2331Online Full Text: dx.doi.org/ (Open Access)
-
Age correlates with response to anti-PD1, reflecting age-related differences in intratumoral effector and regulatory T-Cell populationsIn: Clinical Cancer Research Vol. 24 (2018) Nr. 21, pp. 5347 - 5356Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Circulating cell-free miR-375 as surrogate marker of tumor burden in Merkel cell carcinomaIn: Clinical Cancer Research Vol. 24 (2018) Nr. 23, pp. 5873 - 5882Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosisIn: Circulation Vol. 138 (2018) Nr. 16, pp. 1720 - 1735Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Adjuvant pembrolizumab versus placebo in resected stage III melanomaIn: The New England Journal of Medicine Vol. 378 (2018) Nr. 19, pp. 1789 - 1801Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Antidepressants regulate autophagy by targeting acid sphingomyelinaseIn: Molecular Psychiatry Vol. 23 (2018) Nr. 12, pp. 2251Online Full Text: dx.doi.org/
-
Consensus on molecular imaging and theranostics in prostate cancerIn: The Lancet Oncology Vol. 19 (2018) Nr. 12, pp. e696 - e708Online Full Text: dx.doi.org/
-
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy : a retrospective, multicohort analysisIn: The Lancet Oncology Vol. 19 (2018) Nr. 3, pp. 310 - 322Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Correlation of ctDNA and response in patients (pts) with PDGFRα D842 GIST treated with avapritinibIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii584Online Full Text: dx.doi.org/ (Open Access)
-
Critical influences on the pathogenesis of follicular lymphomaIn: Blood Vol. 131 (2018) Nr. 21, pp. 2297 - 2306Online Full Text: dx.doi.org/ (Open Access)
-
DNA methylation-based classification of central nervous system tumoursIn: Nature Vol. 555 (2018) Nr. 7697, pp. 469 - 474Online Full Text: dx.doi.org/ (Open Access)
-
Distinct Gene Expression Patterns Drive Proliferation of Dominant-Negative RUNX1 Immortalized HSPCs
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Vol. 132 (2018) Nr. Supplement 1, pp. 1795 - 1795Online Full Text: dx.doi.org/ (Open Access) -
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS) : a multicentre, open-label, randomised phase 3 trialIn: The Lancet Oncology Vol. 19 (2018) Nr. 5, pp. 603 - 615Online Full Text: dx.doi.org/; Online Full Text: dx.doi.org/ (Open Access)
-
Establishment of High Rates of Functional Control and Reversal of Fibrosis Following Treatment of Hbeag Negative Chronic HBV Infection with REP 2139-Mg / REP 2165-Mg, Tenofovir Disoproxil Fumarate and Pegylated Interferon Alpha-2aIn: Hepatology Vol. 68 (2018) Nr. S1, pp. 234A - 235AOnline Full Text: dx.doi.org/
-
Impact of dose reduction or dose delay on the efficacy of liposomal irinotecan (nal-IRI)+5-fluorouracil/leucovorin (5-FU/LV) : Survival analysis from NAPOLI-1In: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii250 - viii251Online Full Text: dx.doi.org/ (Open Access)
-
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 4, pp. iv68 - iv78Online Full Text: dx.doi.org/ (Open Access)
-
NAPOLI-1 phase III trial outcomes by prior surgery, and disease stage, in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)In: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii249 - viii250Online Full Text: dx.doi.org/ (Open Access)
-
Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotypeIn: Hepatology Vol. 67 (2018) Nr. 4, pp. 1237 - 1252Online Full Text: dx.doi.org/ (Open Access)
-
Health-related quality of life (HR-QoL) in elderly soft tissue sarcoma (STS) patients from the randomized phase II EPAZ study comparing pazopanib (PAZ) and doxorubicin (DOX) in first lineIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii577Online Full Text: dx.doi.org/ (Open Access)
-
Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib + trametinib (D + T) in patients (pts) with resected BRAF V600-mutant stage III melanomaIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii734 - viii735Online Full Text: dx.doi.org/ (Open Access)
-
Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib plus trametinib (D plus T) in patients (pts) with resected BRAF V600-mutant stage III melanomaIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8,
-
An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphomaIn: Leukemia Vol. 32 (2018) Nr. 1, pp. 92 - 101Online Full Text: dx.doi.org/
-
Corrigendum: Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cellsIn: EMBO Reports Vol. 19 (2018) Nr. 12, pp. e47190Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Author Correction : The landscape of genomic alterations across childhood cancersIn: Nature Vol. 559 (2018) Nr. 7714, pp. E10Online Full Text: dx.doi.org/ (Open Access)
-
Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in miceIn: Hepatology Vol. 68 (2018) Nr. 1, pp. 200 - 214Online Full Text: dx.doi.org/
-
Decreased appetite (DA) at baseline impacts prognosis in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC)In: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 5, pp. v42 - v43Online Full Text: dx.doi.org/ (Open Access)
-
Estimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trialIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii445Online Full Text: dx.doi.org/ (Open Access)
-
Adjuvant vemurafenib in resected, BRAF mutation-positive melanoma (BRIM8) : a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialIn: The Lancet Oncology Vol. 19 (2018) Nr. 4, pp. 510 - 520Online Full Text: dx.doi.org/
-
Antidepressants act by inducing autophagy controlled by sphingomyelin–ceramideIn: Molecular Psychiatry Vol. 23 (2018) Nr. 12, pp. 2324 - 2346Online Full Text: dx.doi.org/ (Open Access)
-
Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCCIn: Hepatology Vol. 68 (2018) Nr. Suppl. 1, pp. 852A - 853A
-
Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus–infected individualsIn: Blood Vol. 131 (2018) Nr. 5, pp. 546 - 557Online Full Text: dx.doi.org/ (Open Access)
-
Helicobacter pylori adhesin HopQ disrupts trans dimerization in human CEACAMsIn: The EMBO Journal Vol. 37 (2018) Nr. 13,Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Prognostic value of baseline biliary stents on outcomes in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the NAPOLI-1 trialIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 5, pp. v42Online Full Text: dx.doi.org/ (Open Access)
-
CEACAM1 promotes CD8⁺ T cell responses and improves control of a chronic viral infectionIn: Nature Communications Vol. 9 (2018) 2561Online Full Text: dx.doi.org/ (Open Access)
-
Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+ T Cell Cross-PrimingIn: Cell Reports Vol. 22 (2018) Nr. 6, pp. 1484 - 1495Online Full Text: dx.doi.org/ (Open Access)
-
IG-MYC⁺ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomasIn: Blood Vol. 132 (2018) Nr. 21, pp. 2280 - 2285Online Full Text: dx.doi.org/ (Open Access)
-
B Cell-Mediated Maintenance of Cluster of Differentiation 169–Positive Cells Is Critical for Liver RegenerationIn: Hepatology Vol. 68 (2018) Nr. 6, pp. 2348 - 2361Online Full Text: dx.doi.org/ (Open Access)
-
Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand BreaksIn: Cell Reports Vol. 25 (2018) Nr. 4, pp. 1040 - 1050.e5Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Soft tissue and visceral sarcomas : ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 4, pp. iv51 - iv67Online Full Text: dx.doi.org/ (Open Access)
-
Overall survival at 4 years of follow-up in a phase III trial of nivolumab plus ipilimumab combination therapy in advanced melanoma (CheckMate 067)In: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii735Online Full Text: dx.doi.org/ (Open Access)
-
The effect of best response to prior anticancer therapy on efficacy outcomes in the NAPOLI-1 trial of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapyIn: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 5, pp. v42Online Full Text: dx.doi.org/ (Open Access)
-
Translational Insights into Gastrointestinal Stromal Tumor and Current Clinical AdvancesIn: Annals of Oncology Vol. 29 (2018) Nr. 10, pp. 2037 - 2045Online Full Text: dx.doi.org/ (Open Access)
-
VOYAGER : An open-label, randomised, phase III study of avapritinib vs regorafenib in patients (pts) with locally advanced (adv) metastatic or unresectable gastrointestinal stromal tumour (GIST)In: Annals of Oncology Vol. 29 (2018) Nr. Suppl. 8, pp. viii595Online Full Text: dx.doi.org/ (Open Access)
-
Correction: Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosaIn: Molecular Psychiatry Vol. 23 (2018) Nr. 9, pp. 1Online Full Text: dx.doi.org/ (Open Access)
-
Imaging of coronary inflammation for cardiovascular risk predictionIn: Lancet Vol. 392 (2018) Nr. 10151, pp. 894 - 896Online Full Text: dx.doi.org/ (Open Access)
-
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeIn: Cell Vol. 175 (2018) Nr. 4, pp. 984 - 997.e24Online Full Text: dx.doi.org/ (Open Access)
-
Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell SubsetsIn: Clinical Cancer Research Vol. 24 (2018) Nr. 19, pp. 4834 - 4844Online Full Text: dx.doi.org/ (Open Access)
-
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable diseaseIn: The Lancet Oncology Vol. 19 (2018) Nr. 3, pp. e151 - e160Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsIn: Nature Genetics Vol. 50 (2018) Nr. 9, pp. 1271 - 1281Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS) : A multicentre, open-label, randomised, phase 3 trialIn: The Lancet Oncology Vol. 19 (2018) Nr. 10, pp. 1315 - 1327Online Full Text: dx.doi.org/
-
A mechanistic classification of clinical phenotypes in neuroblastomaIn: Science Vol. 362 (2018) Nr. 6419, pp. 1165 - 1170Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Role of elevated PHIP copy number as a prognostic and progression marker for cutaneous melanomaIn: Clinical Cancer Research Vol. 24 (2018) Nr. 17, pp. 4119 - 4125Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide–MHC complexesIn: Nature Biotechnology Vol. 36 (2018) Nr. 12, pp. 1191 - 1196Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3 : European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'In: Annals of Oncology Vol. 29 (2018) Nr. 3, pp. 758 - 765Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging GroupIn: The Lancet Oncology Vol. 19 (2018) Nr. 10, pp. e534 - e545Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 BlockadeIn: Cell Vol. 173 (2018) Nr. 3, pp. 624 - 633.e8Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
Differential impact of pure glyphosate and glyphosate-based herbicide in a model of peripheral nervous system myelinationIn: Acta Neuropathologica Vol. 136 (2018) Nr. 6, pp. 979 - 982Online Full Text: dx.doi.org/
-
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapyIn: Clinical Cancer Research Vol. 24 (2018) Nr. 6, pp. 1364 - 1374Online Full Text: dx.doi.org/ (Open Access)
-
Notch-induced myeloid reprogramming in spontaneous pancreatic ductal adenocarcinoma by dual genetic targetingIn: Cancer Research Vol. 78 (2018) Nr. 17, pp. 4997 - 5010Online Full Text: dx.doi.org/ (Open Access)
-
Integrated genomic classification of melanocytic tumors of the central nervous system using mutation analysis, copy number alterations, and DNA methylation profilingIn: Clinical Cancer Research Vol. 24 (2018) Nr. 18, pp. 4494 - 4504Online Full Text: dx.doi.org/ (Open Access)
-
Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosaIn: Molecular Psychiatry Vol. 23 (2018) Nr. 5, pp. 1169 - 1180Online Full Text: dx.doi.org/ (Open Access)
-
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathwaysIn: Nature Communications Vol. 9 (2018) Nr. 1, pp. 4774Online Full Text: dx.doi.org/ (Open Access)
-
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067) : 4-year outcomes of a multicentre, randomised, phase 3 trialIn: The Lancet Oncology Vol. 19 (2018) Nr. 11, pp. 1480 - 1492Online Full Text: dx.doi.org/
-
Sphingolipids as targets for inhalation treatment of cystic fibrosisIn: Advanced Drug Delivery Reviews Vol. 133 (2018) pp. 66 - 75Online Full Text: dx.doi.org/
-
The landscape of genomic alterations across childhood cancersIn: Nature Vol. 555 (2018) Nr. 7696, pp. 321 - 327Online Full Text: dx.doi.org/ (Open Access)
-
Integrative genomic and transcriptomic analysis of leiomyosarcomaIn: Nature Communications Vol. 9 (2018) Nr. 1, pp. 144Online Full Text: dx.doi.org/ (Open Access)
-
Sebaceous tumours: more than skin deepIn: Gut Vol. 67 (2018) Nr. 11, pp. 2045 - 2053Online Full Text: dx.doi.org/
-
PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinomaIn: The New England Journal of Medicine Vol. 379 (2018) Nr. 4, pp. 341 - 351Online Full Text: dx.doi.org/ Online Full Text (Open Access)